彭 艷,程 娟
急診與擇期經(jīng)皮冠狀動(dòng)脈介入術(shù)對(duì)ST段抬高型心肌梗死患者左室重構(gòu)及心功能影響的對(duì)比研究
彭 艷,程 娟
830011新疆烏魯木齊市,新疆心腦血管病醫(yī)院CCU
【摘要】目的比較急診與擇期經(jīng)皮冠狀動(dòng)脈介入術(shù)(PCI)對(duì)ST段抬高型心肌梗死(STEMI)患者左室重構(gòu)及心功能的影響。方法選取2013年3月—2014年3月在新疆心腦血管病醫(yī)院心內(nèi)科行急診PCI的116例STEMI患者作為急診PCI組,行擇期PCI的116例STEMI患者作為擇期PCI組,病情穩(wěn)定未行任何冠狀動(dòng)脈再灌注治療的116例STEMI患者作為對(duì)照組。對(duì)照組患者僅給予對(duì)癥支持治療,未給予靜脈溶栓或PCI等冠狀動(dòng)脈再灌注治療;急診PCI組患者在發(fā)病12~24 h內(nèi)入院,入院后立刻行PCI放置支架;擇期PCI組患者在發(fā)病24 h后入院,7~10 d后行PCI放置支架。比較3組患者發(fā)病1周及6個(gè)月左心室舒張末容積指數(shù)(LVEDVI)、左心室收縮末容積指數(shù)(LVESVI)及左心室射血分?jǐn)?shù)(LVEF);患者均隨訪6個(gè)月,記錄隨訪期間因急性心力衰竭或其他心血管疾病再次住院率。結(jié)果發(fā)病1周,急診PCI組患者LVEDVI、LVESVI小于擇期PCI組和對(duì)照組,LVEF高于擇期PCI組和對(duì)照組(P<0.05);擇期PCI組和對(duì)照組患者LVEDVI、LVESVI及LVEF比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05)。發(fā)病6個(gè)月,急診PCI組患者LVEDVI、LVESVI小于擇期PCI組和對(duì)照組,LVEF高于擇期PCI組和對(duì)照組(P<0.05);擇期PCI組患者LVEDVI、LVESVI小于對(duì)照組,LVEF高于對(duì)照組(P<0.05)。隨訪期間3組患者因急性心力衰竭或其他心血管疾病再次住院率比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05)。結(jié)論急診與擇期PCI均能有效改善STEMI患者的左室重構(gòu)和心功能,但急診PCI的改善效果出現(xiàn)更早、更明顯。
【關(guān)鍵詞】心肌梗死;血管成形術(shù),氣囊,冠狀動(dòng)脈;心室重構(gòu);心功能
彭艷,程娟.急診與擇期經(jīng)皮冠狀動(dòng)脈介入術(shù)對(duì)ST段抬高型心肌梗死患者左室重構(gòu)及心功能影響的對(duì)比研究[J].實(shí)用心腦肺血管病雜志,2016,24(5):68-70.[www.syxnf.net]
Peng Y,Cheng J.Comparative study for influence on left ventricular remodeling and cardiac function of patients with ST-segment elevation myocardial infarction between emergency PCI and elective PCI[J].Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease,2016,24(5):68-70.
ST段抬高型心肌梗死(STEMI)是心內(nèi)科常見(jiàn)的心肌梗死類(lèi)型,是指冠狀動(dòng)脈突然閉塞導(dǎo)致血流中斷或急劇減少,使部分心肌因嚴(yán)重而持久的急性缺血而發(fā)生局部壞死[1];該病的主要臨床表現(xiàn)為劇烈而持久的缺血性胸骨后疼痛、發(fā)熱、白細(xì)胞計(jì)數(shù)增多、紅細(xì)胞沉降率加快、血清心肌酶活性增高及心電圖進(jìn)行性變化,且心電圖顯示典型的ST段抬高是診斷STEMI的重要依據(jù)[2-3]。有研究顯示,心肌梗死后慢性左室重構(gòu)嚴(yán)重?fù)p傷患者的左心室功能,導(dǎo)致并發(fā)癥發(fā)生率和病死率明顯升高[4]。目前,STEMI患者多采用經(jīng)皮冠狀動(dòng)脈介入術(shù)(percutaneous coronary intervention,PCI)進(jìn)行冠狀動(dòng)脈再灌注治療,以改善患者的心功能和左室重構(gòu),降低并發(fā)癥發(fā)生率,從而提高患者的生活質(zhì)量。但急診與擇期PCI哪種方案對(duì)STEMI患者左室重構(gòu)和心功能的改善效果更好,目前尚未明確[5-6]。本研究通過(guò)比較急診PCI、擇期PCI及未行任何冠狀動(dòng)脈再灌注治療的STEMI患者的左室重構(gòu)指標(biāo)、心功能及因急性心力衰竭或其他心血管疾病再次住院率,旨在探討更有效的STEMI治療方案。
1資料與方法
1.1一般資料選取2013年3月—2014年3月在新疆心腦血管病醫(yī)院心內(nèi)科行急診PCI的116例STEMI患者作為急診PCI組,行擇期PCI的116例STEMI患者作為擇期PCI組,病情穩(wěn)定未行任何冠狀動(dòng)脈再灌注治療的116例STEMI患者作為對(duì)照組。3組患者年齡、性別、Killip分級(jí)、心肌梗死部位及合并疾病比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05,見(jiàn)表1),具有可比性。納入標(biāo)準(zhǔn):(1)符合中華醫(yī)學(xué)會(huì)心血管病學(xué)分會(huì)制定的STEMI診斷標(biāo)準(zhǔn)[7];(2)患者簽署知情同意書(shū)。排除標(biāo)準(zhǔn):(1)嚴(yán)重心、肝、腎等重要臟器器質(zhì)性病變或伴精神疾病不能配合者;(2)PCI失敗及對(duì)本研究所用藥物過(guò)敏者。
1.2治療方法對(duì)照組患者僅給予阿司匹林、氯吡格雷及β-受體阻滯劑等對(duì)癥支持治療,未給予靜脈溶栓或PCI等冠狀動(dòng)脈再灌注治療。急診PCI組患者在發(fā)病12~24 h內(nèi)入院,入院后立刻口服阿司匹林300 mg和氯吡格雷300 mg進(jìn)行抗凝治療,然后行PCI放置支架;擇期PCI組患者在發(fā)病24 h后入院,入院后先給予對(duì)癥支持治療,7~10 d后行PCI放置支架。行PCI的患者術(shù)后均給予阿司匹林(100 mg/d)和氯吡格雷(75 mg/d)口服治療,持續(xù)服藥1年并輔助冠心病二級(jí)預(yù)防藥物治療。
1.3觀察指標(biāo)3組患者均于STEMI發(fā)病后1周及6個(gè)月進(jìn)行二維超聲心動(dòng)圖檢查,記錄左心室舒張末容積指數(shù)(LVEDVI)、左心室收縮末容積指數(shù)(LVESVI)及左心室射血分?jǐn)?shù)(LVEF);所有患者隨訪6個(gè)月,記錄隨訪期間因急性心力衰竭或其他心血管疾病再次住院率。
2結(jié)果
2.1LVEDVI、LVESVI及LVEF發(fā)病1周,3組患者LVEDVI、LVESVI及LVEF比較,差異有統(tǒng)計(jì)學(xué)意義(P<0.05);其中急診PCI組患者LVEDVI、LVESVI小于擇期PCI組和對(duì)照組,LVEF高于擇期PCI組和對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05);擇期PCI組和對(duì)照組患者LVEDVI、LVESVI及LVEF比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05)。發(fā)病6個(gè)月,3組患者LVEDVI、LVESVI及LVEF比較,差異有統(tǒng)計(jì)學(xué)意義(P<0.05);其中急診PCI組患者LVEDVI、LVESVI小于擇期PCI組和對(duì)照組,LVEF高于擇期PCI組和對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05);擇期PCI組患者LVEDVI、LVESVI小于對(duì)照組,LVEF高于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05,見(jiàn)表2)。
2.2因急性心力衰竭或其他心血管疾病再次住院率隨訪期間對(duì)照組患者因急性心力衰竭或其他心血管疾病再次住院5例,再次住院率為3.45%;擇期PCI組患者因急性心力衰竭或其他心血管疾病再次住院2例,再次住院率為1.72%;急診PCI組患者無(wú)一例因急性心力衰竭或其他心血管疾病再次住院。3組患者因急性心力衰竭或其他心血管疾病再次住院率比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(χ2=5.540,P=0.063)。
表1 3組患者一般資料比較
注:a為F值
表2 3組患者發(fā)病1周和發(fā)病6個(gè)月LVEDVI、LVESVI及LVEF比較
注:LVEDVI=左心室舒張末容積指數(shù),LVESVI=左心室收縮末容積指數(shù),LVEF=左心室射血分?jǐn)?shù);與對(duì)照組比較,aP<0.05;與擇期PCI組比較,bP<0.05
3討論
心肌梗死發(fā)生后心肌和非心肌細(xì)胞缺血、細(xì)胞外基質(zhì)表達(dá)改變等多種因素會(huì)導(dǎo)致心臟梗死區(qū)域和非梗死區(qū)域結(jié)構(gòu)、代謝和功能發(fā)生改變,嚴(yán)重?fù)p傷患者的心功能,易導(dǎo)致左室重構(gòu)[8]。目前臨床上治療心肌梗死常行PCI放置支架以疏通梗死血管,從而改善左室重構(gòu)及心功能。PCI是指通過(guò)穿刺股動(dòng)脈或橈動(dòng)脈等將導(dǎo)管、導(dǎo)絲、球囊沿動(dòng)脈送至冠狀動(dòng)脈相應(yīng)的狹窄部位,進(jìn)而進(jìn)行擴(kuò)張以消除冠狀動(dòng)脈狹窄的一種新型的微創(chuàng)治療技術(shù),其可有效降低左心室容量,提高心臟射血功能,但急診PCI和擇期PCI哪種治療方式能更有效地緩解STEMI患者左室重構(gòu)和心功能尚未明確[9-10]。Guerra等[11]研究認(rèn)為,急診PCI和擇期PCI均能有效改善STEMI患者的左室重構(gòu)和心功能,但急診PCI更有效,能在心肌梗死早期降低患者左心室容積、提高心臟射血能力。為此,本研究比較了擇期與急診PCI對(duì)STEMI患者左室重構(gòu)和心功能的影響。
LVEDVI是反映左室重構(gòu)的一項(xiàng)重要指標(biāo),其增大提示左心室舒張末期容量增加,左心室舒張末期壓力(前負(fù)荷)增加,進(jìn)而引起左心房壓力、肺靜脈壓力增加;其減小則提示左心室舒張末期容量減少,可導(dǎo)致心臟向主動(dòng)脈射血減少,從而引起周?chē)毖Y狀。LVESVI與LVEDVI恰好相反,但均屬于反映左室重構(gòu)的重要指標(biāo)。LVEF是指每搏輸出量占心室舒張末期容量的百分比,與心肌收縮能力有關(guān),心肌收縮能力越強(qiáng)每搏輸出量越多,LVEF越高。正常情況下LVEF≥50%,LVEF<50%則提示心功能不全。
本研究結(jié)果顯示,發(fā)病1周,急診PCI組患者LVEDVI、LVESVI小于擇期PCI組和對(duì)照組,LVEF高于擇期PCI組和對(duì)照組;擇期PCI組和對(duì)照組患者LVEDVI、LVESVI及LVEF間無(wú)差異;提示急診PCI能早期改善STEMI患者的左室重構(gòu)和心功能。發(fā)病6個(gè)月,急診PCI組患者LVEDVI、LVESVI小于擇期PCI組和對(duì)照組,LVEF高于擇期PCI組和對(duì)照組;擇期PCI組患者LVEDVI、LVESVI小于對(duì)照組,LVEF高于對(duì)照組;提示擇期和急診PCI均能有效改善STEMI患者的左室重構(gòu)和心功能,且急診PCI的改善效果更明顯。本研究通過(guò)進(jìn)一步隨訪發(fā)現(xiàn),3組患者因急性心力衰竭或其他心血管疾病再次住院率間無(wú)差異。
綜上所述,急診PCI與擇期PCI均能有效改善STEMI患者的左室重構(gòu)和心功能,但急診PCI的改善效果出現(xiàn)更早、更明顯。
參考文獻(xiàn)
[1]Ben-Zvi D, Savion N, Kolodgie F,et al.Local Application of Leptin Antagonist Attenuates Angiotensin II-Induced Ascending Aortic Aneurysm and Cardiac Remodeling[J].J Am Heart Assoc,2016,5(5):e003474.
[2]劉鴻宇.不同治療方法對(duì)老年急性心梗死患者近期預(yù)后比較[J].中國(guó)基層醫(yī)藥,2013,20(16):2408-2410.
[3]Hristova K,Vasilev D,Pavlov P,et al.How ischemia affect the distribution of myocardial deformation parameters according to long term progression of regional kinetics in patients with acute and chronic myocardial infarction?[J].Eur Heart J,2013,34(12):409.
[4]Vakili H,Sadeghi R,Tabkhi M,et al.Corrected thrombolysis in myocardial infarction frame count and ejection fraction in patients undergoing primary percutaneous coronary intervention for myocardial infarction[J].ARYA Atheroscler,2013,9(2):134-139.
[5]蘇少輝,葉健烽,何小萍,等.急性心肌梗死患者冠狀動(dòng)脈內(nèi)超選擇應(yīng)用替羅非班的臨床研究[J].中華老年醫(yī)學(xué)雜志,2015,34(7):732-735.
[6]Karwat KP,Tomala M,Miszalski-Jamka K,et al.Left atrial contractile strain is the independent predictor of LV remodeling after ST-segment elevation myocardial infarction[J].Journal of Cardiovascular Magnetic Resonance,2015,17(1):1-2.
[7]Antoniucci D.Block the ischemia and reperfusion damage: an old adjunctive drug for a new reperfusion strategy[J].J Am Coll Cardiol,2014,63(22):2363-2364.
[8]He X,Wan X,Luo M,et al.Ultra Early Routine Post-Fibrinolysis Angioplasty Benefits More Patients with Acute ST-Elevation Myocardial Infarction[J].Open Access Library Journal,2014,1(9):1-7.
[9]趙瑞平,杜偉.碎裂QRS波與急性心肌梗死患者預(yù)后的相關(guān)性[J].臨床心電學(xué)雜志,2013,22(5):341-344.
[10]de Waha S,Eitel I,Desch S,et al.Thrombus Aspiration in ThrOmbus containing culpRiT lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI): study protocol for a randomized controlled trial[J].Trials,2013,14:110.
[11]Guerra E,Hadamitzky M,Ndrepepa G,et al.Microvascular obstruction in patients with non-ST-elevation myocardial infarction:a contrast-enhanced cardiac magnetic resonance study[J].Int J Cardiovasc Imaging,2014,30(6):1087-1095.
(本文編輯:謝武英)
Comparative Study for Influence on Left Ventricular Remodeling and Cardiac Function of Patients With ST-segment Elevation Myocardial Infarction Between Emergency PCI and Elective PCI
PENGYan,CHENGJuan.
CCUofXinjiangHospitalforCardio-cerebrovascularDisease,Urumqi830011,China
【Abstract】ObjectiveTo compare the influence on left ventricular remodeling and cardiac function of patients with ST-segment elevation myocardial infarction between emergency PCI and elective PCI.MethodsFrom March 2013 to March 2014 in the Department of Cardiology,Xinjiang Hospital for Cardio-cerebrovascular Disease,116 ST-segment elevation myocardial infarction patients undergoing emergency PCI were selected as A group,116 ST-segment elevation myocardial infarction patients undergoing elective PCI were selected as B group,116 ST-segment elevation myocardial infarction patients did not receive any coronary artery reperfusion therapy were selected as C group.Patients of C group received symptomatic and supportive treatment,did not received intravenous thrombolysis or PCI,patients of A group received emergency PCI within 12 to 24 hours after attack,while patients of B group received elective PCI within 7 to 10 days after admission.LVEDVI,LVESVI and LVEF after 1 week,6 months of attack were compared among the three groups;all of the patients were followed up for 6 months,and the incidence of rehospitalization caused by acute heart failure or other cardiovascular disease was recorded.ResultsAfter 1 week of attack,LVEDVI and LVESVI of A group were statistically significantly smaller than those of B group and C group,while LVEF of A group was statistically significantly higher than that of B group and C group,respectively(P<0.05);no statistically significant differences of LVEDVI,LVESVI or LVEF was found between B group and C group(P>0.05).After 6 months of attack,LVEDVI and LVESVI of A group were statistically significantly smaller than those of B group and C group,while LVEF of A group was statistically significantly higher than that of B group and C group,respectively(P<0.05);LVEDVI and LVESVI of B group were statistically significantly smaller than those of C group,while LVEF of B group was statistically significantly higher than that of C group(P<0.05).No statistically significant differences of rehospitalization rate caused by acute heart failure or other cardiovascular disease was found among the three groups during the follow-up(P>0.05).ConclusionBoth of emergency PCI and elective PCI can effectively relieve the left ventricular remodeling and improve the cardiac function,but emergency PCI has more early and more effective improvement effect.
【Key words】Myocardial infarction;Angioplasty,balloon,coronary;Ventricular remodeling;Cardiac function
【中圖分類(lèi)號(hào)】R 542.22
【文獻(xiàn)標(biāo)識(shí)碼】B
doi:10.3969/j.issn.1008-5971.2016.05.017
(收稿日期:2016-02-14;修回日期:2016-05-07)
·療效比較研究·